# grunenthal.com > AI-optimized mirror of grunenthal.com containing 50 pages totalling 33,183 words of clean markdown content, structured data, and semantic HTML. Original source: https://grunenthal.com. Last updated: 2026-09-07T02:42:34.525Z. Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG). ## Homepage - [site-root.html](/content/site-root.html): Walls.io collects and displays all social media content for your hashtag campaign, branded social hub, or event, Grünenthal is a global leader in pain management and related diseases. Our purpose is to change lives for the better – and innovation is our passion. We focus our activities on moving towards our vision of a world free of pain. (590 words) ## Articles & Blog Posts - [Chronic post-surgical pain (CPSP): A Key Pain Condition | Grünenthal](/content/science/pain-insights/chronic-post-surgical-pain/index.html): Learn about the common symptoms, causes and treatment options for chronic post-surgical pain, including neuropathic pain, and get to know about its diagnosis, management and unmet needs. (1,896 words) - [Complex regional pain syndrome (CRPS): A Key Pain Condition | Grünenthal](/content/science/pain-insights/complex-regional-pain/index.html): Learn about the common symptoms, causes and treatment options for complex regional pain syndrome and get to know about its diagnosis, management and unmet needs. (1,565 words) - [Chronic Low Back Pain: A Key Pain Condition | Grünenthal](/content/science/pain-insights/chronic-low-back-pain/index.html): Learn about the common symptoms, causes, and treatment options for chronic low back pain and its diagnosis, management, and unmet needs. (1,449 words) - [Understanding Pain | Grünenthal](/content/world-free-of-pain/understanding-pain/index.html): This text provides an overview of pain types, outlines the differences between acute and chronic pain, and describes the personal and economic impact that chronic pain can have. (1,275 words) - [Grünenthal's development pipeline | Grünenthal](/content/science/pipeline/index.html): We are currently pursuing a range of programmes across different modalities, targets, and mechanisms of action (1,217 words) - [Company | Grünenthal](/content/company/index.html): Grünenthal is a science-based, privately-owned pharmaceutical company headquartered in Aachen, Germany with a long track record in pain research., Our Grünenthal Company Overview provides information about our key objectives and activities, as well as our recent business development highlights and financial performance. (2,554 words) - [Manufacturing Sites | Grünenthal](/content/company/global-capabilities/manufacturing-sites/index.html): Our plants in Germany, Switzerland, Italy, Ecuador and Chile cover the complete supply chain – from the production of formulations to final packaging and shipping. (881 words) - [Affiliates in USA & Latin America | Grünenthal](/content/company/global-capabilities/affiliates-usa-latin-america/index.html): Contact details of Grünenthal affiliates in USA & Latin America (255 words) - [History | Grünenthal](/content/company/history/index.html): Grünenthal is an independent, family-owned integrated research and development company with more than 50 years of experience in pain research (737 words) - [Classification of pain | Grünenthal](/content/world-free-of-pain/pain-basics/classification-of-pain/index.html): Learn about the different ways pain can be classified, according to aetiology, pathophysiology, anatomical location, intensity, duration and ICD-11. (1,370 words) - [Pain Management | Grünenthal](/content/world-free-of-pain/pain-management/index.html): The Pain Management Hub has been developed to support and raise awareness among primary care physicians regarding the responsible use of pain medication. This educational content has been developed in close collaboration with a multidisciplinary group of experts – each a healthcare professional involved in the management of patients with pain – and is based on their personal clinical experience as well as published literature. (1,070 words) - [Disclosure Grünenthal | Grünenthal](/content/company/compliance-ethics-transparency/disclosure-of-transfers-of-value/index.html): Overview of Grünenthal Disclosures to HCP, HCO, Patient Organisations and related to Research and Development Activities (742 words) - [Tegacorat (GRM-01) Digital Library | Grünenthal](/content/science/pipeline/tegacorat-digital-library/index.html): Scientific links and resources for GRM (Glucocorticoid Receptor Modulator) (156 words) - [Meet Grünenthal scientists | Grünenthal](/content/science/meet-the-scientists/index.html): Meet Grünenthal's scientific experts (465 words) - [Management of Pain | Grünenthal](/content/world-free-of-pain/pain-basics/management-of-pain/index.html): Learn about implementing a practical biopsychosocial approach, multimodal therapy, and non-pharmacological and pharmacological treatments. (1,737 words) - [Clincal data sharing Grünenthal | Grünenthal](/content/science/clinical-trial-transparency/data-sharing/index.html): Grünenthal will share patient- and trial-level data from clinical trials with suitably qualified scientific and medical researchers as necessary for conducting legitimate research. (416 words) - [Grünenthal supported pain-related projects and initiatives | Grünenthal](/content/world-free-of-pain/initiatives/index.html): Grünenthal is involved in several impact-driven initiatives that help pain patients return to everyday living quickly and sustainably. (756 words) - [Grünenthal‘s Leadership Team | Grünenthal](/content/company/leadership/index.html): Leadership at Grünenthal means the ability to work beyond functions, to step out of roles and an interest in how we can do the best for the business overall. (253 words) - [Grünenthal product portfolio | Grünenthal](/content/company/products/index.html): Grünenthal’s product portfolio, brands, ingredients and indication range. (820 words) - [EFIC-Grünenthal-Grant (E-G-G) | Grünenthal](/content/world-free-of-pain/initiatives/e-g-g/index.html): EFIC-Grünenthal-Grant (E-G-G) is a world-leading innovation grant that has funded pioneering research for two decades. (535 words) - [Clinical Trial Portal | Grünenthal](/content/science/clinical-trial-transparency/index.html): Grünenthal Clinical Trials Portal - latest research on conditions, including phase and status information. (329 words) - [Gabriel Baertschi Chief Executive Officer Grünenthal | Grünenthal](/content/company/leadership/gabriel-baertschi/index.html): Gabriel Baertschi Chairman of the Corporate Executive Board and Chief Executive Officer, Grünenthal Group since 2016 (375 words) - [Research and Development - Our Science | Grünenthal](/content/science/index.html): We focus our R&D efforts on pain, epilepsy, pruritus, and neurodegenerative disorders. (456 words) - [Duchenne muscular dystrophy (DMD) | Grünenthal](/content/science/pipeline/duchenne-muscular-dystrophy/index.html): Duchenne muscular dystrophy (DMD - A genetic disease with a devastating impact. (961 words) - [Pain Insights | Grünenthal](/content/science/pain-insights/index.html): Gain in-depth knowledge on ten key pain conditions with high unmet need (292 words) - [Fabian Raschke Chief Financial Officer Grünenthal | Grünenthal](/content/company/leadership/fabian-raschke/index.html): Fabian Raschke, Member of the Corporate Executive Board, Chief Financial Officer, Grünenthal since 2019 (309 words) - [2025 EFPIA Disclosure Grünenthal | Grünenthal](/content/company/compliance-ethics-transparency/efpia-disclosure-2025/index.html): Grünenthal Disclosure Reports stating transfers of value done to HCPs and HCOs during 2025 published with a methodological note how Grünenthal is collecting and disclosing the data. (328 words) - [2023 EFPIA Disclosure Grünenthal | Grünenthal](/content/company/compliance-ethics-transparency/efpia-disclosure-2023/index.html): Disclosure of Transfers of Value to Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) Grünenthal 2023 (386 words) - [Disclosure Non-EFPIA Countries 2023-2025 | Grünenthal](/content/company/compliance-ethics-transparency/non-efpia-countries/index.html): Grünenthal Disclosure Reports for non Efpia countries stating transfers of value done to HCPs and HCOs during 2023-2025 published in local registries. (119 words) - [Patient Collaborations | Grünenthal](/content/world-free-of-pain/patient-collaboration/index.html): Grünenthal is committed to embedding patient engagement through each stage in the lifecycle of our medicines and beyond. (504 words) - [Change Pain Grünenthal - A medical education initiative | Grünenthal](/content/world-free-of-pain/initiatives/change-pain/index.html): Change Pain aims to create a better understanding of pain patients’ needs and develop solutions that improve pain management. (252 words) - [2024 EFPIA Disclosure Grünenthal | Grünenthal](/content/company/compliance-ethics-transparency/efpia-disclosure-2024/index.html): Grünenthal Disclosure Reports stating transfers of value done to HCPs and HCOs during 2024 published with a methodological note how Grünenthal is collecting and disclosing the data. (328 words) - [Data Clinical Trials | Grünenthal](/content/science/clinical-trial-transparency/data-clinical-trials/index.html): As a research-based pharmaceutical company, Grünenthal recognizes the importance of publicly registering clinical trials and making information including results available. Please consult the table below to easily find information on Grünenthal sponsored clinical trials. (491 words) - [Jan Adams Chief Commercial Officer Grünenthal | Grünenthal](/content/company/leadership/jan-adams/index.html): Jan Adams, M. D., assumed the role of Chief Commercial Officer and Member of the Corporate Executive Board of Grünenthal in October 2024. (349 words) - [Pathophysiology | Grünenthal](/content/world-free-of-pain/pain-basics/pathophysiology/index.html): Learn about the different pain mechanisms and about pain chronification. (721 words) - [Supervisory Board Grünenthal | Grünenthal](/content/company/supervisory-board/index.html): The Supervisory Board advises and controls the Corporate Executive Board of the Grünenthal Group. (721 words) - [Our company culture at Grünenthal | Grünenthal](/content/company/culture/index.html): Grünenthal promotes a company culture and set of shared values that inspire our teams to pursue a World Free of Pain – everyday, everywhere, every one of us. (356 words) - [Physician Unmet Needs | Grünenthal](/content/world-free-of-pain/pain-basics/unmet-needs/index.html): Learn about the gap in patient–physician communication, the balancing act of pain relief and side effects, and the importance of urgency in diagnosis and treatment. (701 words) - [Compliance and transparency | Grünenthal](/content/company/compliance-ethics-transparency/index.html): Conducting our business responsibly is a core part of our strategy and culture, and we aspire to have a net positive impact on the societies we operate in. (745 words) - [Quentin Le Masne de Chermont Head of Corporate Strategy and Business Development Grünenthal | Grünenthal](/content/company/leadership/quentin-le-masne-de-chermont/index.html): Quentin Le Masne de Chermont extended board team member Grünenthal (189 words) - [Leen Hofkens Head Global Human Resources Grünenthal | Grünenthal](/content/company/leadership/leen-hofkens/index.html): Vita Leen Hofkens, Head Global Human Resources, Member of Grünenthal’s Extended Management Board (185 words) - [Grünenthal's global presence & production sites | Grünenthal](/content/company/global-capabilities/index.html): Grünenthal is presented in 28 countries and maintains production sites in five countries. (121 words) - [A World Free of Pain | Grünenthal](/content/world-free-of-pain/index.html): Our company has spent more than half a century battling pain – and that long struggle has given us uniquely deep expertise in this field. (555 words) - [Key Pain Conditions | Grünenthal](/content/world-free-of-pain/key-pain-conditions/index.html): Learn in-depth knowledge about pain conditions with high unmet needs. (125 words) - [Comprehensive assessment | Grünenthal](/content/world-free-of-pain/pain-basics/comprehensive-assessment/index.html): Learn about comprehensive assessment; case history, pain history, general medical history and psychosocial history, as well as pain intensity versus functioning (functionality). (905 words) - [Uli Brödl Chief Scientific Officer Grünenthal | Grünenthal](/content/company/leadership/uli-broedl/index.html): Prof. Dr. Uli Brödl assumed the role of Chief Scientific Officer and Member of the Corporate Executive Board in February 2025. (299 words) - [Press releases | Grünenthal](/content/press-room/press-releases/index.html): Archive of Grünenthal press releases published from 2019 onwards. (541 words) - [Definition of pain | Grünenthal](/content/world-free-of-pain/pain-basics/definition-of-pain/index.html): Learn about the definition of pain and the biopsychosocial model of chronic pain. (382 words) - [Research and Development Collaboration | Grünenthal](/content/science/research-and-development-collaboration/index.html): As a deeply experienced company with a specialisation in the therapeutic area of pain, we share our capabilities with partners at every stage in the development process. (419 words) ## Resources - [Full Page Index](/index.html): Browse all cached pages with rich metadata - [About This Cache](/about.html): Methodology, technical details, and usage guidelines - [XML Sitemap](/sitemap.xml): Machine-readable sitemap for crawler discovery - [Robots.txt](/robots.txt): Crawler directives - [AgentSite Network](https://agentsite.network/network.html): Public index of AgentSites and their machine-readable resources